EUVIMEDEUVIMED entdecken
Crossref

Serum Cytokine Profiles in Patients with Rheumatoid Arthritis Before and After Treatment with Methotrexate

Manoj Lama iD, Rajat Sarkar, Bappaditya Ghosh

Journal of Interferon & Cytokine Research · 01.08.2023 · 43 (8) · 344-350

DOI: 10.1089/jir.2023.0078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Interferon & Cytokine Research, erschienen am 01.08.2023. Verfasst von Manoj Lama und 2 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Immunology Laboratory, Department of Zoology, University of Gour Banga, Malda, India. Hauptthemen laut MEDLINE: Methotrexate, Arthritis, Rheumatoid, Cytokines, Antirheumatic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is an inflammatory autoimmune illness affecting around 1% of the population globally. Cytokines have a crucial role in the pathogenesis of RA. The objectives of the present study were to compare the serum cytokine profiles between methotrexate (MTX)-treated and MTX-naive RA patient groups, MTX-treated RA patient group and healthy controls, and MTX-naive RA patient group and healthy controls. Enzyme linked immunosorbent assay (ELISA) kits were used to quantify the serum concentrations of tumor necrosis factor-alpha (TNF-α), interleukin (IL)-1β, IL-17, IL-6, interferon-gamma (IFN-γ), and IL-10 in 80 RA patients (48 MTX treated and 32 MTX naive) and 80 healthy controls. For all cytokine assays, absorbance was measured at 450 nm using a microplate reader (Bio-Rad). Independent sample t-test was used to compare the serum cytokine concentrations between the study groups using SPSS version 25. MTX-treated RA patient group had significantly reduced serum levels of TNF-α (36.13 ± 17.64 versus 45.82 ± 23.07, *P = 0.037), IL-17 (307.85 ± 151.74 versus 435.42 ± 241.19, **P = 0.006), and IFN-γ (414.93 ± 212.13 versus 527.15 ± 269.61, *P = 0.041) compared to MTX-naive RA patients. Both MTX-treated and MTX-naive RA patient groups had significantly high serum levels of TNF-α, IL-1β, IL-17, IL-6, IFN-γ, and IL-10 when compared to healthy controls (***P < 0.001). Downregulation of the serum concentrations of certain key cytokines, viz. TNF-α, IL-17, and IFN-γ, demonstrates the anti-inflammatory effect of MTX in RA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateArthritis, RheumatoidCytokinesAntirheumatic AgentsHumansMaleFemaleMiddle AgedAdultCase-Control Studies

Stichwörter der Autor:innen

IFN-γIL-17IL-1βTNF-αmethotrexaterheumatoid arthritis

Substanzen

MethotrexateCytokinesAntirheumatic Agents

Autor:innen und Institutionen

  • Molecular Immunology Laboratory, Department of Zoology, University of Gour Banga, Malda, India.
  • Department of Orthopaedics, Malda Medical College and Hospital, Malda, India.

ORCID-Profile: Manoj Lama

Zitieren

APA

Lama, M., Sarkar, R., & Ghosh, B. (2023). Serum Cytokine Profiles in Patients with Rheumatoid Arthritis Before and After Treatment with Methotrexate. Journal of Interferon & Cytokine Research, 43(8), 344-350. https://doi.org/10.1089/jir.2023.0078

Vancouver

Lama M, Sarkar R, Ghosh B. Serum Cytokine Profiles in Patients with Rheumatoid Arthritis Before and After Treatment with Methotrexate. Journal of Interferon & Cytokine Research. 2023;43(8):344-350. doi:10.1089/jir.2023.0078

BibTeX
@article{Lama2023,
  author = {Lama, Manoj and Sarkar, Rajat and Ghosh, Bappaditya},
  title = {Serum Cytokine Profiles in Patients with Rheumatoid Arthritis Before and After Treatment with Methotrexate},
  journal = {Journal of Interferon & Cytokine Research},
  year = {2023},
  volume = {43},
  number = {8},
  pages = {344--350},
  doi = {10.1089/jir.2023.0078}
}
Kostenlos starten →